Putnam Investments LLC Uni Qure N.V. Transaction History

Putnam Investments LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$35.98 - $47.66 $4.31 Million - $5.71 Million	-119,900 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$45.06 - $67.74 $4.49 Million - $6.75 Million	99,586 Added 490.23%	119,900 $5.4 Million
Q1 2020 May 15, 2020	SELL	$40.01 - $73.97 $1.54 Million - $2.84 Million	-38,386 Reduced 65.39%	20,314 $964,000
Q4 2019 Feb 14, 2020	SELL	$37.13 - $74.62 $827,999 - $1.66 Million	-22,300 Reduced 27.53%	58,700 $4.21 Million
Q3 2019 Nov 14, 2019	BUY	$39.36 - $76.8 $3.19 Million - $6.22 Million	81,000 New	81,000 $3.19 Million

142

35.3M

1.54M

389K

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $300M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

Get notified when there are updates to the investment portfolio of Putnam Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Putnam Investments LLC with notifications on news.